Risk for Subdeltoid Bursitis After Influenza Vaccination
Elisabeth M. Hesse(Epidemic Intelligence Service), Jonathan Duffy(Centers for Disease Control and Prevention), Ousseny Zerbo(Kaiser Permanente), Scott C. Olson(Marshfield Clinic), Lisa A. Jackson(Kaiser Permanente Washington Health Research Institute), Chengyi Zheng(Kaiser Permanente), James D. Nordin(HealthPartners), Michelle L. Henninger(Kaiser Permanente Center for Health Research), Darios Getahun(Kaiser Permanente), Ronald A. Navarro(Kaiser Permanente), Matthew F. Daley(Kaiser Permanente)
Cited by 26
Related Papers
The health status of adults on the autism spectrum
|Autism|2015|1.1k
Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration — United States, 2020
|MMWR Morbidity and Mortality Weekly Report|2020|720
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
|New England Journal of Medicine|2021|661
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
|MMWR Morbidity and Mortality Weekly Report|2021|602